0 of 7 Questions completed
You have already completed the quiz before. Hence you can not start it again.
Quiz is loading…
You must sign in or sign up to start the quiz.
You must first complete the following:
0 of 7 Questions answered correctly
Time has elapsed
You have reached 0 of 0 point(s), (0)
Earned Point(s): 0 of 0, (0)
0 Essay(s) Pending (Possible Point(s): 0)
You must score 0% to continue. Please click the link below to re-take the quiz
1. How confident are you in the management of patients with severe asthma in your practice?
2. FeNO levels of ≥25 ppb are predictive of response for which biologic(s) that are approved for severe asthma?
3. The combination of higher eosinophils and FeNO act synergistically to predict what?
4. Alyssa, a 19-year-old patient with lifelong perennial allergies and severe, persistent asthma that was diagnosed at age 12 has a FeNO level of 21 ppb and blood eosinophils of 265 cells/µL. Which of the available biologics should be considered for her, per GINA guidelines?
5. Which biologic would be most appropriate for Aidan, a 10-year-old male with moderate atopic dermatitis as well as severe asthma with blood eosinophils of 180 cells/μL and a FeNO level of 36 ppb?
6. According to the GINA guidelines, if a patient with severe asthma has shown a good response to biologic therapy for a trial of 6 to 12 months, how often should he or she be reevaluated?
7. Courtney is a 32-year-old woman with severe eosinophilic asthma who started taking an anti-IL-5 biologic 4 months ago. She has experienced some reduction in symptoms and exacerbations but is not completely satisfied with the treatment as she is still experiencing symptoms that require frequent use of rescue inhaler. Which of the following should be your next step?